KELFER - 250 Price

Overview

Welcome to Dwaey, specifically on KELFER - 250 Capsules (Hard Gelatin) page.
This medicine contains an important and useful components, as it consists of Deferiprone.
KELFER - 250 is available in the market in concentration 250mg/Capsule and in the form of Capsules (Hard Gelatin).

CIPLA LTD. is the producer of KELFER - 250 and it is imported from INDIA, The most popular alternatives of KELFER - 250 are listed downward .

Mode Of Action

Deferiprone is an orally effective iron-chelating agent. It is being used when desferrioxamine is unsuitable or contraindicated.

Indication

• Thalassaemia
• Iron overload

Precaution

Hepatic and renal impairment. Neutropenia, monitor neutrophil count wkly and discontinue treatment if neutropenia develops. Limited experience in children 6-10 yr. Lactation: Unknown whether distributed in breast milk; because of the potential for adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Side Effects

• >10% Chromaturia (14.6%)
• Nausea (12.6%)
• Abdominal pain/discomfort (10.4%) 1-10% Arthralgia (9.8%)
• Vomiting (9.8%)
• Increased ALT (7.5%)
• Decreased neutrophil count (7.3%)
• Neutropenia (6.2%)
• Increased appetite (4%)
• Diarrhea (3%)
• Headache (2.5%)
• Dyspepsia (2%)
• Back pain (2%)
• Extremity pain (1.9%)
• Increased weight (1.9%)
• Agranulocytosis (1.7%)
• Arthropathy (1.4%)
• Increased AST (1.2%)
• Decreased appetite (1.1%)

Contra indication

Agranulocytosis, pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.